Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Shenlu Pharmaceutical (Hefei) is a pharmaceutical manufacturing company based in Hefei, China, and a subsidiary of the state-owned China Resources Pharmaceutical Group. The company originated from a strategic joint venture involving Novartis and China Resources, though it has since been fully integrated into the China Resources (CR) Pharma ecosystem. It specializes in the production of both Traditional Chinese Medicine (TCM) and chemical generic drugs, with a strong focus on respiratory, cardiovascular, and otorhinolaryngological health. The company operates large-scale, GMP-certified manufacturing facilities that serve as a key production hub for the Anhui region. Its portfolio includes well-established local brands for cough and cold relief, as well as essential medicines for chronic disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hefei China Resources Novartis Pharmaceutical.